SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-020801
Filing Date
2017-04-18
Accepted
2017-04-18 07:00:35
Documents
5
Period of Report
2017-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v464398_8k.htm 8-K 20336
2 EXHIBIT 10.1 v464398_ex10-1.htm EX-10.1 27380
3 EXHIBIT 99.1 v464398_ex99-1.htm EX-99.1 11765
4 GRAPHIC ex10-1_logo.jpg GRAPHIC 13302
5 GRAPHIC ex99-1_logo.jpg GRAPHIC 13322
  Complete submission text file 0001144204-17-020801.txt   97731
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 17765980
SIC: 2834 Pharmaceutical Preparations